Quadrant Capital Group LLC Meridian Bioscience Inc Transaction History

Quadrant Capital Group LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$31.15 - $33.39 $7,164 - $7,679	-230 Reduced 55.16%	187 $6,000
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $7,910 - $8,588	256 Added 159.01%	417 $13,000
Q2 2022 Aug 09, 2022	BUY	$23.75 - $31.69 $285 - $380	12 Added 8.05%	161 $5,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $1,110 - $1,440	64 Added 75.29%	149 $3,000
Q2 2021 Aug 09, 2021	BUY	$18.01 - $28.32 $180 - $283	10 Added 13.33%	85 $2,000
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $37,169 - $110,417	-4,741 Reduced 98.44%	75 $2,000
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $26,825 - $55,384	4,816 New	4,816 $41,000
Q2 2019 Jul 24, 2019	SELL	$10.88 - $17.6 $20,389 - $32,982	-1,874 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$15.51 - $17.61 $23,699 - $26,908	1,528 Added 441.62%	1,874 $31,000
Q3 2018 Oct 29, 2018	SELL	$14.85 - $16.35 $29,700 - $32,700	-2,000 Reduced 85.25%	346 $4,000
Q2 2018 Aug 09, 2018	BUY	$13.8 - $16.8 $27,600 - $33,600	2,000 Added 578.03%	2,346 $35,000
Q1 2018 May 10, 2018	SELL	$13.8 - $16.2 $2.19 Million - $2.57 Million	-158,360 Reduced 99.78%	346 $4,000
Q2 2017 Aug 15, 2017	BUY	N/A	158,706	158,706 $2.49 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.